Fuyong Du
Impact in
-
- Diabetes Treatment and Management
- Toxicology top 10%
Papers in
-
- Diabetes Treatment and Management 9
- Menopause: Health Impacts and Treatments 2
-
- Metabolism, Diabetes, and Cancer 3
- Receptor Mechanisms and Signaling 3
- Co-authors
- Keith T. Demarest (9 shared papers)Yin Liang (10 shared papers)Xiaofeng Yang (2 shared papers)June Xu (4 shared papers)David Polidori (2 shared papers)Yi Liu (1 shared paper)Anthony Virtue (1 shared paper)Kenji Arakawa (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Analytical Biochemistry (1 paper)Biomarker Research (1 paper)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Fuyong Du
19 papers receiving 819 citations
Peers
Comparison fields: 5 of 89
- Endocrinology, Diabetes and Metabolism 246
- Toxicology 21
- Molecular Biology 351
- Organic Chemistry 141
- Pharmacology 73
Countries citing papers authored by Fuyong Du
This map shows the geographic impact of Fuyong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuyong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuyong Du more than expected).
Fields of papers citing papers by Fuyong Du
This network shows the impact of papers produced by Fuyong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuyong Du. The network helps show where Fuyong Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuyong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 201 | |
| 2 | 2016 | 170 | |
| 3 | 2012 | 110 | |
| 4 | 2009 | 90 | |
| 5 | 2013 | 54 | |
| 6 | 2006 | 41 | |
| 7 | 2011 | 39 | |
| 8 | 2018 | 29 | |
| 9 | 2018 | 26 | |
| 10 | 2006 | 18 | |
| 11 | 2017 | 14 | |
| 12 | 2018 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2017 | 9 | |
| 15 | 2023 | 4 | |
| 16 | 2019 | 3 | |
| 17 | 2016 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2019 | 1 |
About Fuyong Du
Fuyong Du is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Oncology, Surgery and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 833 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Metabolism, Diabetes, and Cancer (3 papers), Receptor Mechanisms and Signaling (3 papers), Pancreatic function and diabetes (3 papers), Estrogen and related hormone effects (2 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Menopause: Health Impacts and Treatments (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (246 citations), Toxicology (21 citations), Molecular Biology (351 citations), Organic Chemistry (141 citations) and Pharmacology (73 citations). Fuyong Du has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Keith T. Demarest, Yin Liang, Xiaofeng Yang, June Xu, David Polidori, Yi Liu, Anthony Virtue, Kenji Arakawa, Kiichiro Ueta and Tonya Martin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Analytical Biochemistry and Biomarker Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.